Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel ...

It is currently not possible to cure cystic fibrosis. However, medications and airway clearance techniques can help a person manage the condition. In severe cases, a doctor may recommend a lung ...

For people with cystic fibrosis, like Sabrina Walker, Trikafta has been a life-changer. Before she started taking the drug, she would wind up in the hospital for weeks at a time until antibiotics ...

Maren Denison, third-year student at the University of Iowa, was in sixth grade when she found out her lung function had dropped to 60 percent as half of her lung had collapsed and was scarred shut.

After pausing a trial for a Moderna-partnered cystic fibrosis candidate due to subpar tolerability, Vertex Pharmaceuticals ...

Vanzacaftor-tezacaftor-deutivacaftor, a novel therapeutic, once-daily drug, demonstrates noninferiority to elexacaftor-tezacaftor-ivacaftor (the twice-daily, standard-of-care drug) in lung function ...

Vertex Pharmaceuticals ended a Phase 1/2 study of an inhaled cystic fibrosis treatment developed jointly with Moderna after the study showed "persistent tolerability issues" with the drug. The ...

Getting your Trinity Audio player ready... Colorado’s new prescription drug review board decided in a first-in-the-nation vote that a medication costing more than $200,000 a year doesn’t qualify as ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...

While many people with cystic fibrosis (CF) and COVID-19 have a mild to moderate illness, others are at a high risk of serious illness. This includes those who have a history of lung transplants or ...